Amsterdam-based biotech company, VectorY, has appointed Alexander Vos as CEO, and Dr Sander van Deventer as CTO. The appointments come in the wake of the company closing a €31m (US$37.6m)…
Amsterdam-based biotech company, VectorY, has appointed Alexander Vos as CEO, and Dr Sander van Deventer as CTO. The appointments come in the wake of the company closing a €31m (US$37.6m)…
…
Rankings & Reports
M&A
Equity
Healthcare Investing Review
Healthcare Real Assets Report
Resources & Events
Resource Hub
Sector Events
Private Capital Conference
Real Assets Conference


